From Bench to Bedside: Viral Hepatitis, ESCMID Postgraduate Education Course
13 - 14 November 2009, Istanbul, Turkey
Organizers
Jointly organized by the ESCMID Study Group for Viral Hepatitis (ESGVH) and the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD).
Course Objectives
- Increase knowledge about viral hepatitis
- Review the epidemiology, prevention and outcome of viral hepatitis
- Enhance attendees’ understanding of diagnosis of hepatitis
- Increase knowledge about the treatment of viral hepatitis and follow-up
- Demonstrate through case discussions all the steps to diagnose and treat chronic viral hepatitis
Course Venue
The Green Park Hotel, Bostanci, Istanbul, Turkey
Hotel Website
Target Audience
Infectious diseases and clinical microbiology specialists and trainees, gastroenterologists and clinicians taking care of patients with viral hepatitis.
Contact Person
Prof Hakan Leblebicioglu
Department of Infectious Diseases & Clinical Microbiology
Ondokuz Mayis University Medical School
Samsun, Turkey
Phone +90 362 312 1919/2480
hakanomu[at]yahoo.com
Course Programme
All presentations are available for ESCMID members. Please login or register.
Friday, 13 November 2009
Diagnosis of viral hepatitis
Chairs: Haluk Vahaboglu, Andy Hoepelman
- Genotyping of viral hepatitis: do we need it? Mithat Bozdayi
- HBV DNA quantification: How? When? Valeria Ghisetti
- Occult hepatitis B. Resat Ozaras
- Staging and grading of chronic viral hepatitis. Cenk Sokmensuer
Acute viral hepatitis: treatment and prevention
Chairs: Iftihar Koksal, Dominique Salmon
- Treatment of acute hepatitis C: to wait or not to wait. Will Irwing
- Fulminant viral hepatitis and transplantation. Yilmaz Cakaloglu
- Viral hepatitis in pregnancy. Hasan S.Z. Aksu
- Prevention of Hepatitis B, C, D. J.E. Arends
Workshops: Case studies (three groups in rotation)
- Group A: Discussion and interpretation of viral hepatitis serology. Hakan Leblebicioglu
- Group B: Autoimmune hepatitis and interpretation of liver related tests (e.g. ANA, ASMA etc.). Ramazan Idilman
- Group C: Liver cirrhosis. Necati Ormeci
Saturday, 14 November 2009
Treatment of chronic hepatitis B
Chairs: Fehmi Tabak, Valeria Ghisetti
- HBV drug resistance and management. Hans L Zaaijer
- Management of chronic hepatitis B: making the right choice. J.E. Arends
- Treatment of non-responders. Bulent Degertekin
Treatment of chronic hepatitis C
Chairs: Gaye Usluer, Will Irwing
- HCV viral kinetics and predictors of response. Hakan Senturk
- Tailored therapy of chronic hepatitis C. Nurdan Tozun
- Treatment of non-responders. Philippe Sogni
- New hepatitis C antiviral drugs. Hakan Erdem
Workshop: Case studies (three groups in rotation)
- Group A: Co-infection, HIV-HBV, HBV-HCV, HIV-HBV-HCV. Dominique Salmon
- Group B: Clinical management of immuncompromised patients with chronic hepatitis B. Ran Tur-Kaspa
- Group C: Side effect management of treatment of chronic hepatitis C. Can Polat Eyigun
PowerPoint
PDF
Webcast
Text
Image
Video
